A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor

Francesca Bugli, Maurizio Sanguinetti, Maurizio Martini, Riccardo Torelli, Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, Marija Stepanović, Arianna Mancini, Enrico Rango, Giulia Iovenitti, Alessio Molinari, Laura Maccari, Massimo Valoti, Elena Dreassi, Maurizio Botta, Milica Pešić, Silvia Schenone

Research output: Contribution to journalArticle

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences